Capital World Investors’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Capital World Investors’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-343,544	Closed	-$32.7M	–	572
2019 Q2	$32.7M	Buy	343,544 +240	+0.1%	+$22.6K	0.01%	384
2019 Q1	$31.3M	Hold	343,304	–	–	0.01%	383
2018 Q4	$26.1M	Hold	343,304	–	–	0.01%	404
2018 Q3	$27.5M	Buy	+343,304	New	+$32M	0.01%	438
2017 Q3	–	Sell	-777,914	Closed	-$88M	–	528
2017 Q2	$88M	Sell	777,914 -525,504	-40%	-$58.7M	0.02%	294
2017 Q1	$131M	Sell	1,303,418 -971,017	-43%	-$104M	0.03%	265
2016 Q4	$245M	Sell	2,274,435 -105,740	-4%	-$12.4M	0.06%	213
2016 Q3	$296M	Sell	2,380,175 -508,307	-18%	-$60M	0.08%	195
2016 Q2	$307M	Buy	2,888,482 +21,159	+0.7%	+$2.46M	0.08%	187
2016 Q1	$328M	Buy	2,867,323 +1,034,029	+56%	+$121M	0.09%	182
2015 Q4	$261M	Buy	1,833,294 +803,294	+78%	+$92.7M	0.07%	211
2015 Q3	$92.5M	Buy	1,030,000 +11,000	+1%	+$1.16M	0.03%	293
2015 Q2	$117M	Buy	+1,019,000	New	+$107M	0.03%	290

Other funds holding CBPO

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

YCMGA

York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Capital World Investors's CBPO Position: Q3 2019 in Review

Capital World Investors sold out of China Biologic Products Holdings, Inc. (CBPO) in Q3 2019, closing a stake of 343,544 shares — an estimated $32.7M sold.

Capital World Investors first reported a position in CBPO in Q2 2015 and held it in 13 quarters. The position peaked at $328M in Q1 2016. 88 funds tracked by Wall St. Rank hold CBPO as of Q3 2019.

Capital World Investors reported no remaining China Biologic Products Holdings, Inc. position as of Q3 2019 after selling out during the quarter.
Capital World Investors sold 343,544 China Biologic Products Holdings, Inc. shares in Q3 2019, an estimated $32.7M.
Capital World Investors first reported a position in China Biologic Products Holdings, Inc. in Q2 2015 and held it in 13 quarters.
Capital World Investors's China Biologic Products Holdings, Inc. position peaked at $328M in Q1 2016.
88 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q3 2019.

Based on Capital World Investors's 13F filing for Q3 2019, filed 14 Nov 2019.